-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nautilus Biotechnology, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2020 to Q1 2024.
- Nautilus Biotechnology, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$16.3M, a 29.9% decline year-over-year.
- Nautilus Biotechnology, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$51.7M, a 12.9% decline from 2022.
- Nautilus Biotechnology, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$45.8M, a 16.7% decline from 2021.
- Nautilus Biotechnology, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$39.2M, a 180% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)